Pfizer Inc. (PFE)

NYSE - NYSE Real Time Price. Currency in USD
32.27+0.09 (+0.28%)
As of 10:53 AM EDT. Market open.
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close32.18
Bid32.20 x 1900
Ask32.21 x 14300
Day's Range32.20 - 32.36
52wk Range28.25 - 37.39
1y Target EstN/A
Market Cap195.74B
P/E Ratio (ttm)28.61
Avg Vol (3m)18,959,096
Dividend & Yield1.20 (3.73%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Market Realist48 minutes ago

    Treating Epilepsy Is One of Pfizer’s Solid Growth Prospects

    In the US, Pfizer (PFE)’s Lyrica is protected by its composition of matter patent until December 30, 2018. However, the drug lost regulatory exclusivity in major European markets in July 2014.

  • Market Realist3 hours ago

    Analyst Recommendations for Pfizer and Its Peers in 2016

    Based on the recommendations of 27 brokerage firms in a Bloomberg survey, 57.7% of analysts gave Pfizer (PFE) a “buy” recommendation while 42.3% analysts rated the company a “hold.” None of the analysts ...

  • Financial Times11 hours ago

    [$$] A CEO's primer on how to manage under pressure

    Leaders often define themselves by bold acts: a takeover, a corporate rescue. Success, though, is determined by a trait less obvious to outsiders their ability to handle pressure. Dennis Kozlowski told ...